Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
What and how much should we discuss with patients?
- At: Dublin (Ireland) (2013)
- Type: Presentation
- By: ASLANI, Parisa (Australasian Pharmaceutical Science Association, Australia)
Abstract not available.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019